About Peter Vanderklish
Form D filings for Spinogenix from 2020 to 2024 list Peter Vanderklish as executive officer.
Peter Vanderklish first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Peter Vanderklish in the role, so the role may have started earlier or lasted longer.
Spinogenix, Inc.
Executive officer
2020 – 2024 · Los Angeles, CA
Develops experimental medicines for people with neurological and psychiatric conditions.
Key Colleagues at Startups
The people Peter Vanderklish works with at each company, as listed on that company's latest Form D.
Spinogenix, Inc. · Form D, Jun 21, 2024
MT
Mervyn Turner
Director
DA
Dan Albosta
Executive officer
SS
Stella Sarraf
Executive officer and director
Jerre Stead
Director